Why the study?
Does the combined evaluation of nonfasting apolipoprotein B and triglycerides predict coronary heart disease risk in healthy middle-aged men?
Does the combined evaluation of nonfasting apolipoprotein B and triglycerides predict coronary heart disease risk in healthy middle-aged men?
The combined evaluation of nonfasting apoB and triglycerides provides useful diagnostic criteria for predicting CHD risk, adding prognostic value beyond lifestyle factors.
No takes yet. Share an insight, caveat, or question.
ApoB/apoA-I ratio and combined apoB/TGs associated with CHD risk beyond lifestyle; hypothesis-generating for risk stratification.
Talmud et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: